PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmacy Department, University College London Hospitals NHS Foundation Trust, UCLH-UCL Centre for Medicines Optimisation Research and Education, London, UK.\', \'Department for Targeted Intervention, UCL/UCLH Surgical Outcomes Research Centre, Centre for Perioperative Medicine, University College London, London, UK.\', \'Health Services Research Centre, National Institute for Academic Anaesthesia, Royal College of Anaesthetists, London, UK.\', \'Rapid Research Evaluation and Appraisal Lab (RREAL), London, UK.\', \'Department of Anaesthesia and Perioperative Medicine, University College London Hospitals NHS Foundation Trust, London, UK.\', \'Department of Applied Health Research, University College London, London, UK.\', \'Institute of Epidemiology and Healthcare, University College London, London, UK.\', \'UCL Institute for Global Health, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1177/10781552211015767
?:doi
?:hasPublicationType
?:journal
  • Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
is ?:pmid of
?:pmid
?:pmid
  • 33983080
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Global changes to the chemotherapy service during the covid-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all